The Importance of Clinical Trials
By Arya Baladevigan, ACS CAN Volunteer (IN-05)
FOR MORE INFORMATION, CONTACT:
American Cancer Society Cancer Action Network
Phone: 508-450-8690 (cell)
E-mail: [email protected]
ACS CAN Statement on Oral Chemotherapy Fairness Compromise
JUNE 18, 2015 – Yesterday, New Hampshire House and Senate conferees reached a deal on enacting oral chemotherapy fairness in the Granite State. The original legislation, Senate Bill 137, had previously received a unanimous Senate committee vote and widespread bi-partisan support.
The following can be attributed to Mike Rollo, New Hampshire director of government relations for the American Cancer Society Cancer Action Network (ACS CAN):
“ACS CAN thanks the conferees for their willingness to compromise and for bringing relief to high out-of-pocket costs for cancer patients. We are especially grateful to the bill’s prime sponsor, Sen. Jeb Bradley, for his leadership on this issue. This deal is a step in the right direction for the more than 8,000 Granite Staters who will be diagnosed with cancer this year.
“This legislation will help ensure cancer patients have access to the most effective forms of treatment without having to be concerned with outrageous co-pays. Thanks to strong leadership by Sen. Bradley and his colleagues, New Hampshire is now on the path to join 39 other states and Washington, D.C. in ensuring affordable access to oral chemotherapy.”
ACS CAN, the nonprofit, nonpartisan advocacy affiliate of the American Cancer Society, supports evidence-based policy and legislative solutions designed to eliminate cancer as a major health problem. ACS CAN works to encourage elected officials and candidates to make cancer a top national priority. ACS CAN gives ordinary people extraordinary power to fight cancer with the training and tools they need to make their voices heard. For more information, visit www.fightcancer.org.